Related Experiment Video
Updated: Dec 21, 2025

Acute Myocardial Infarction in Rats
Published on: February 16, 2011
2019-Novel Coronavirus-Related Acute Cardiac Injury Cannot Be Ignored
Yueying Wang1, Leonardo Roever2, Gary Tse1
1Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular disease, Department of Cardiology, Tianjin Institute of Cardiology, Second Hospital of Tianjin Medical University, Tianjin, 300211, People's Republic of China.
Insights
COVID-19, caused by SARS-CoV-2, can lead to cardiac injury. This review summarizes the prevalence and mechanisms of acute cardiac injury in COVID-19 patients, highlighting the role of ACE2 receptors.
Area of Science:
- Cardiology
- Infectious Diseases
- Virology
Background:
- Coronavirus disease 2019 (COVID-19), caused by SARS-CoV-2, is a global pandemic.
- While primarily respiratory, SARS-CoV-2 infection is associated with cardiac injury.
- Cardiac injury is an independent predictor of adverse outcomes in COVID-19.
Purpose of the Study:
- To review the prevalence of acute cardiac injury in COVID-19.
- To explore the underlying mechanisms of SARS-CoV-2-related myocardial injury.
- To emphasize the clinical significance of cardiac complications during the pandemic.
Main Methods:
- Literature review of studies on COVID-19 and cardiac injury.
- Analysis of reported cardiovascular complications in SARS-CoV-2 infected patients.
- Investigation of potential mechanisms involving ACE2 receptors and related pathways.
Main Results:
- Cardiovascular complications are frequently observed in COVID-19 patients.
- The angiotensin-converting enzyme-2 (ACE2) receptor pathway is implicated in myocardial injury.
- Mechanisms of cardiac injury in SARS-CoV-2 infection require further elucidation.
Conclusions:
- Acute cardiac injury is a significant concern in COVID-19.
- Understanding the mechanisms is crucial for patient management.
- Routine cardiac function assessment is recommended for COVID-19 patients.
Purpose Of The Review:
Coronavirus disease 2019 (COVID-19), a new infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), has reached a pandemic status. Although SARSCoV-2 causes primarily respiratory problems, concurrent cardiac injury cannot be ignored since it may be an independent predictor for adverse outcomes. To resolve these issues, we aim to summarize the prevalence and its underlying mechanisms of acute cardiac injury in the setting of SARS-CoV-2 infection.
Recent Findings:
The main clinical manifestation of SARS-CoV-2 infection is pneumonia, cardiovascular complications have also been identified in the earliest reported cases from Wuhan, the epicenter of the outbreak. Given the SARS-CoV-2 likely uses the angiotensin-converting enzyme-2 (ACE2) receptors as its host receptor, ACE2-related signaling pathways may play a key role in mediating myocardial injury. SARS-CoV-2 infection related acute cardiac injury cannot be ignored, and its underlying mechanisms remain speculated. We would suggest that health professionals investigate cardiac function as part of the routine care.
More Related Videos
03:13Technical Refinement of a Bilateral Renal Ischemia-Reperfusion Mouse Model for Acute Kidney Injury Research
Published on: November 3, 2023
09:36Halogenated Agent Delivery in Porcine Model of Acute Respiratory Distress Syndrome via an Intensive Care Unit Type Device
Published on: September 24, 2020
Related Concept Videos
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome V: Nursing Management
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome III: Diagnostic Studies
Introduction Cardiac Emergencies